International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 4

Short Communication | Medical Science | Volume 10 Issue 5, May 2021 | Pages: 618 - 619 | India


Long Term Abuse of Domperidone causing Hyperprolactinemia

Dr Shubha Agrawal

Abstract: MDR Kochs patient on AKT since September 2019 along with proton pump inhibitor+Domperidone sustained release tablets since 9 months twice a day for gastritis and nausea, vomiting. Over a period of time kochs was getting healed however patient started complaining of increase in weight and breast since April 2020. Patient's TSH level was 5.63uIU/ml and prolactin level -76.97 ng/ml (normal range forTSH-0.45-4.5 uIU/ml and prolactin level -5.18-26.53 ng/ml). As a chest physician I started looking for AKT or any other drug induced causes of hyperprolactinemia. Patient refused to stop domperidone and started thyroid supplement.

Keywords: domperidone, hyperprolactinemia, medicine, adverse drug reactions

How to Cite?: Dr Shubha Agrawal, "Long Term Abuse of Domperidone causing Hyperprolactinemia", Volume 10 Issue 5, May 2021, International Journal of Science and Research (IJSR), Pages: 618-619, https://www.ijsr.net/getabstract.php?paperid=SR201105123040, DOI: https://dx.doi.org/10.21275/SR201105123040

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.